The Thromboxane Receptor as a New Brain Target for Alzheimer’s

The Thromboxane Receptor as a New Brain Target for Alzheimer’s
Thromboxane ReceptorResearchers at Temple University blocked the thromboxane brain cell receptor, stopping oxidative stress in an Alzheimer’s mouse model, and preventing key symptoms of the disease. In Alzheimer’s disease two pathological proteins accumulate in the brain: beta-amyloid protein and hyper-phosphorylated tau. Both are thought to wreak havoc by causing progressive brain cell death, possibly in part through a process known as oxidative stress. The brain needs oxygen to functio
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *